VRTX   $477.92  0.79% Market Closed After Close 479.5 0.33%

Vertex Pharmaceuticals Inc
Total Cash 5.80B
totalCashPerShare 22.454
EBITDA 4.39B
Total Debt 933.40M
quickRatio 2.101
currentRatio 2.521
Total Revenue 10.34B
debtToEquity 6.318
Revenue/Share 40.075
ROA 0.12963
ROE -0.0324
grossProfits
freeCashflow 2.89B
operatingCashflow -944.00M
earningsGrowth
revenueGrowth 0.061
grossMargins 0.53648996
ebitdaMargins 0.42515
operatingMargins 0.35338002
profitMargins -0.04739
enterpriseValue 120.41B
forwardPE 27.360203
floatShares 257.33M
sharesOutstanding 258.10M
sharesShort 4.38M
sharesShortPriorMonth 5.08M
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.00%
heldPercentInstitutions 0.96%
Short Ratio help_outline 3.58%
shortPercentOfFloat 0.02%
impliedSharesOutstanding
bookValue 57.263
Price To Book help_outline 8.48
earningsQuarterlyGrowth
netIncomeToCommon -489.90M
trailingEps -1.99%
forwardEps 17.74%
enterpriseToEbitda 27.40
lastDividendValue
lastDividendDate
currentQuarterEstimate 4.1 3Q 2024
institutionsCount 2232
lastUpdated Sept. 16, 2024, 11:29 a.m.